BT
BioXcel Therapeutics Inc
🇺🇸XNAS.BTAIUnited StatesHealthcare
$0.04USDdown -0.01 (-20%)OpenEnd of day6:03 PM
Price$0.04-0.01 (-20%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US09075P2048
- CUSIP
- 09075P105
Company
- Employees
- 29
- Headquarters
- New Haven, United States
- CEO
- Dr. Vimal D. Mehta Ph.D.
Market
- Shares outstanding
- 31.3M
- Market cap
- $1.25M
Highlights
- Market cap
- $1.57M
- EPS LTM
- -$2.26calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.02calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $742K-14.52%down year on year
- Net income
- -$70.86M-39.08%down year on year
- Gross margin
- 45.28%+131.32%up year on year
- Free cash flow
- -$50.9M+8.72%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.